BioSpace News Archive

Astellas today announced that Geoff Towle has been promoted to vice president, Oncology Marketing, Astellas US.

EVIO Inc. (“EVIO” or the “Company”), (OTCQB: EVIO), a leading provider of cannabis testing and scientific research for the regulated cannabis industry in North America, announced that its Massachusetts lab has engaged in a Community Host agreement with the City of Framingham to proceed with licensing as an independent testing laboratory under the Commission’s recently adopted adult use regulations.

or the past month, motorists travelling along St. Louis’ two major highways have witnessed a feast of lush, leafy collards, kale and chard growing on two “living billboards” featuring the iconic St. Louis Arch standing tall in front of the downtown skyline.

Capital BlueCross is proud to announce it has been named as one of the Best Places to Work in Pennsylvania for 2018. It is among 100 companies across the commonwealth chosen for the honor.

Immune-Onc Therapeutics (“Immune-Onc”), a privately held cancer immunotherapy company dedicated to the discovery and development of novel biologic treatments for cancer patients, today announced the appointments of Dr. Adrian Jubb as Chief Medical Officer and of Dr. An Song as Senior Vice President of Development Sciences.

The global cognition supplements market is expected to post a CAGR of close to 14% during the period 2018-2022, according to the latest market research report by Technavio.

To further increase the efficiency of the Professional Hygiene business, Essity is closing its converting facility in Bellemont, Arizona, United States.

In coordination with the back-to-school season, the San Fernando Valley Community Mental Health Center, Inc. has unveiled a telephone hotline and webpage for students being bullied or parents concerned about bullying.

Investigators at Children’s Hospital Los Angeles have been able to pinpoint the exact stage of development of the human retina, when cells can grow out of control and form cancer-like masses. The finding could open the door for future interventions in retinoblastoma (RB), a tumor of the retina that affects children under five years of age.

Technavio has announced their latest drug pipeline analysis report on herpes zoster